Milea Timbergen

225 Table 1. Review of literature Patient Reported Outcome Measurements (PROM) Score 1. Score 2. / additional interests Ref. N (N- PROM) Location T Outcome Pre-treatment Outcome Post-treatment DASH - 24 14 (1) a UE SG NA a n = 1 DASH 38 (after interthoracoscapular amputation) MSTS score 25 12 (1) a UE SG NA a n = 1 MSTS 50% b (pain 2, function 1, acceptance 2, hand positioning 4, dexterity 3, lifting 3), DASH 62.5 b Enneking score / MSTS score - 26 21 UE SG BT NA mean MSTS 79% b (range 57% - 97%) n = 10 (48%) excellent; n =1 0 (48%) good; n = 1 (4%) medium pain functional impairment 27 7 UE SG, ARTx CT NA mean MSTS 73% (range: 36-90%), n = 5 moderate functional impairment of the shoulder, n = 1 deficit flexion and extension of the elbow. n = 2 pain with use of medication TESS 28 14 (1) a UE SG NA a n = 1 MSTS 50 (pain 3, function 2, acceptance 5, hand positioning 0, dexterity 5, lifting 0), TESS 62 EORTC QLQ- C30 19 14 AW SG NA mean global health status b : 97 (± 5.9); physical functioning 93 (± 11.1); role functioning 89 (± 16.7); emotional functioning 87 (± 19.1); cognitive functioning 94 (± 8.3); social functioning 93 (± 14.7) MDASI - 29 17 AS GSI NA mean symptom severity: partial responders (n = 5): 1.65 point improvement, stable disease (n = 5): 0.8 point improvement, no response/ dropout (n = 7) 0.04 point improvement 8